We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+9.21%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.75B
AUM Growth
+$188M
Cap. Flow
+$19.8M
Cap. Flow %
0.72%
Top 10 Hldgs %
19.69%
Holding
327
New
32
Increased
100
Reduced
149
Closed
29

Top Buys

Rank Stock Value
1
DPLO
DIPLOMAT PHARMACY, INC.
DPLO
+$19.1M
2
APOG icon
Apogee Enterprises
APOG
+$15.9M
3
DNOW icon
DNOW Inc
DNOW
+$15.1M
4
PINC
Premier
PINC
+$13.4M
5
SUM
Summit Materials, Inc. Class A Common Stock
SUM
+$12.4M

Top Sells

Rank Stock Value
1
SUPN icon
Supernus Pharmaceuticals
SUPN
+$25.9M
2
STMP
Stamps.com, Inc.
STMP
+$17.4M
3
VSAT icon
Viasat
VSAT
+$17M
4
CVGW
Calavo Growers
CVGW
+$15.3M
5
REVG
REV Group
REVG
+$15.1M

Sector Composition

Rank Sector Weight
1 Healthcare 22.97%
2 Industrials 19.87%
3 Technology 17.13%
4 Consumer Discretionary 9.66%
5 Communication Services 7.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTMD icon
276
Utah Medical Products
UTMD
$225M
$377K 0.01%
3,421
+58
+2% +$6.06K
OKE icon
277
Oneok
OKE
$54.5B
$349K 0.01%
5,000
-200
-4% -$12.9K
CPLA
278
DELISTED
Capella Education Company
CPLA
$316K 0.01%
3,202
+55
+2% +$5.13K
IWC icon
279
iShares Micro-Cap ETF
IWC
$1.52B
$313K 0.01%
2,965
-106
-3% -$10.8K
T icon
280
AT&T
T
$163B
$310K 0.01%
12,800
+1,256
+11% +$31.5K
MCHP icon
281
Microchip Technology
MCHP
$46B
$309K 0.01%
6,800
-42,506
-86% -$1.97M
NVCR icon
282
NovoCure
NVCR
$1.91B
$300K 0.01%
+9,587
New +$267K
BRK.A icon
283
Berkshire Hathaway Class A
BRK.A
$1.12T
$282K 0.01%
1
– –
WDFC icon
284
WD-40
WDFC
$3.15B
$271K 0.01%
1,850
-300
-14% -$41.3K
RMCF icon
285
Rocky Mountain Chocolate Factory
RMCF
$7.84M
$268K 0.01%
23,425
+404
+2% +$4.66K
BMY icon
286
Bristol-Myers Squibb
BMY
$132B
$255K 0.01%
4,608
– –
TRUE
287
DELISTED
TrueCar
TRUE
$249K 0.01%
24,687
+425
+2% +$4.18K
DENN
288
DELISTED
Denny's
DENN
$226K 0.01%
14,208
+242
+2% +$3.85K
XEL icon
289
Xcel Energy
XEL
$48.8B
$223K 0.01%
4,871
– –
JPM icon
290
JPMorgan Chase
JPM
$950B
$214K 0.01%
2,058
– –
LLY icon
291
Eli Lilly
LLY
$1.06T
$212K 0.01%
+2,490
New +$205K
BP icon
292
BP
BP
$107B
$211K 0.01%
+4,903
New +$206K
PG icon
293
Procter & Gamble
PG
$339B
$206K 0.01%
2,639
– –
MMM icon
294
3M
MMM
$94.3B
$197K 0.01%
1,197
– –
AAPL icon
295
Apple
AAPL
$4.57T
$167K 0.01%
3,600
– –
AUTO
296
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$78K ﹤0.01%
17,247
+298
+2% +$1.11K
CODA icon
297
Coda Octopus Group
CODA
$120M
$74K ﹤0.01%
+19,266
New +$74.8K
SPWH icon
298
Sportsman's Warehouse
SPWH
$46M
$65K ﹤0.01%
12,610
+217
+2% +$1.09K
AEIS icon
299
Advanced Energy
AEIS
$13B
– –
-172,827
Closed -$11M
AXON
300
Axon Enterprise
AXON
$46.4B
– –
-288,288
Closed -$11.3M
10 11
12
13 14

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Rice Hall James & Associates's Q2 2018 Portfolio in Review

As of Q2 2018, Rice Hall James & Associates held 327 positions worth $2.75B, up 7.3% from $2.56B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Rice Hall James & Associates's Q2 2018 filing shows 32 new, 100 increased, 149 reduced and 29 closed positions. Its largest new stake was DIPLOMAT PHARMACY, INC.: 818,939 shares worth $20.9M. The largest sale was Supernus Pharmaceuticals, an estimated $25.9M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Industrials and Technology.

  • Rice Hall James & Associates's largest Q2 2018 buy was DIPLOMAT PHARMACY, INC.: 818,939 shares worth $20.9M.
  • Rice Hall James & Associates added most to Apogee Enterprises in Q2 2018, an estimated $15.9M increase.
  • Rice Hall James & Associates's biggest Q2 2018 reduction was Supernus Pharmaceuticals, cutting an estimated $25.9M.
  • Rice Hall James & Associates fully exited Viasat in Q2 2018, selling an estimated $17M.
  • Rice Hall James & Associates's ten largest holdings make up 20% of its $2.75B portfolio in Q2 2018.
  • Rice Hall James & Associates opened 32 new positions and closed 29 in Q2 2018.
  • Rice Hall James & Associates's portfolio value rose 7.3% quarter-over-quarter to $2.75B.

Based on Rice Hall James & Associates's 13F filing for Q2 2018, filed 2 Aug 2018.